Moderna could have to wait until as late as December to analyse data from its Covid-19 vaccine trial, longer than would be necessary to meet the Trump administration’s hopes of issuing an emergency approval ahead of the US election.
Moderna可能最迟要等到12月才能分析其新型冠状病毒肺炎（COVID-19，即2019冠状病毒病）疫苗试验的数据，这比希望在美国大选之前发布紧急批准的特朗普政府期待的速度要慢。
您已阅读8%（323字），剩余92%（3787字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。